Ann: Suspension from Official Quotation - Annual Listing Fees, page-8

Was hard not to really considering every trial they advanced was positive and advanced onto the next step Phase 3 non opioid cancer pain drug. Look at observational study findings as well. 3 tga approved Nanocelle medications.. Nanocelle as a whole is a winner. Is why we are all confused. Considering all other cannabis space asx companies burnt as much or more funds with nothing near advanced as Nanocelle. Patented in 57 world wide until 2036...Not like they ever reported negative trial results like some I could name still listed burning loads more cash than MDC with no income since ipo and in exuberant debt. There are a few that come to mind.